CHARACTERIZATION OF A PUTATIVE HIV-1 REGULATORY PROTEIN

Information

  • Research Project
  • 3144797
  • ApplicationId
    3144797
  • Core Project Number
    R01AI029856
  • Full Project Number
    5R01AI029856-02
  • Serial Number
    29856
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/1991 - 34 years ago
  • Project End Date
    2/29/1996 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    3/1/1992 - 33 years ago
  • Budget End Date
    2/28/1993 - 32 years ago
  • Fiscal Year
    1992
  • Support Year
    2
  • Suffix
  • Award Notice Date
    3/9/1992 - 33 years ago

CHARACTERIZATION OF A PUTATIVE HIV-1 REGULATORY PROTEIN

DESCRIPTION: (Adapted from applicant's abstract) One of the specific aims of this application is to examine the physical characteristics of DNA:protein interactions between NFAT-1 (nuclear factor of activated T cells, a trans-activating factor that binds to a cis-acting element in the interleukin-2 [IL-2] enhancer) and cognate sites. These sites include those in the IL-2 enhancer and HIV LTR (long terminal repeat). Another goal of the investigator is to try to purify NFAT-1. The applicant also proposes to analyze the ability of the putative NFAT-1 binding site in the HIV LTR to confer inducible transcriptional activity to a linked promoter. Lastly, Dr. Edwards will try to explore the function of NFAT-1 in the life cycle of HIV, including a potential role in the initial infection of susceptible T cells and the possible involvement of NFAT-1 in the breakdown of latency. Preliminary data obtained by the applicant suggest that recognition sites for NFAT-1 have remarkable sequence divergence. Consequently, she is interested in examining the correlation between in vitro binding characteristics of NFAT-1-binding sites in IL-2 and HIV and their ability to influence the level and inducibility of transcription in vivo.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R01
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ARRC
  • Study Section Name
    AIDS and Related Research Study Section 3
  • Organization Name
    GENELABS TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    REDWOOD CITY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    940634737
  • Organization District
    UNITED STATES